tvt news Haberler
“Clairity’s FDA authorization is a turning point for more women to access the scientific advances of AI-driven cancer risk prediction,” Larry Norton, founding scientific director of the Breast Cancer Research Foundation, wrote in another statement. “Breast cancer is rising, especially among younger women, yet most risk models often miss those who will develop the disease,” he said. “Now we can …
Read More »FDA approves first AI tool to predict breast cancer risk
